After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Patients can now receive interventional techniques that are no longer palliative in nature,” stated Samir Khan, DO, provider ...

I was under the impression that only older adults got shingles,” says Mangini, who was 37 at the time. The rash spread, yet ...

While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Research indicates that musculoskeletal surgery shouldn't be the first stop for a health plan member in chronic pain.